Skip to main content
. 2018 Feb 7;15(4):3231–3238. doi: 10.3892/etm.2018.5843

Figure 3.

Figure 3.

Thymosin α1 treatment inhibits pro-inflammatory TNF-α and promotes anti-inflammatory IL-10. Plasma (A) TNF-α and (B) IL-6 levels. Data are expressed as the mean ± standard error of the mean (n=3). *P<0.05 vs. the CG group. TNF-α, tumor necrosis factor-α; IL-10, interleukin-10; CG, control group; MG, model group; TG, treatment group.